VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
50 hedge funds and large institutions have $33.6M invested in Viracta Therapeutics, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
31% less capital invested
Capital invested by funds: $48.8M → $33.6M (-$15.3M)
33% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 12
Holders
50
Holding in Top 10
1
Calls
$816K
Puts
$258K
Top Buyers
| 1 | +$1.09M | |
| 2 | +$182K | |
| 3 | +$158K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$154K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$153K |
Top Sellers
| 1 | -$6.72M | |
| 2 | -$441K | |
| 3 | -$290K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$229K |
| 5 |
TI
Telemetry Investments
New York
|
-$178K |